Literature DB >> 25652573

Situating the trovan trial with the use of experimental ebola therapies is like comparing an apple with an orange.

Muhammed O Afolabi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25652573     DOI： 10.1007/s11673-015-9619-7

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN： 1176-7529            Impact factor:   1.352


× No keyword cloud information.
  9 in total

1.  Secret report surfaces showing that Pfizer was at fault in Nigerian drug tests.

Authors:  Jeanne Lenzer
Journal:  BMJ       Date:  2006-05-27

2.  Pfizer settles with victims of Nigerian drug trial.

Authors:  Jeanne Lenzer
Journal:  BMJ       Date:  2011-08-16

Review 3.  Ethical considerations of experimental interventions in the Ebola outbreak.

Authors:  Annette Rid; Ezekiel J Emanuel
Journal:  Lancet       Date:  2014-08-22       Impact factor: 79.321

4.  Compassionate use of experimental drugs in the Ebola outbreak.

Authors:  Morenike Folayan; Brandon Brown; Aminu Yakubu; Kristin Peterson; Bridget Haire
Journal:  Lancet       Date:  2014-09-11       Impact factor: 79.321

5.  WHO meeting chooses untried interventions to defeat Ebola.

Authors:  John Maurice
Journal:  Lancet       Date:  2014-09-20       Impact factor: 79.321

6.  Ethical challenges posed by the Ebola virus epidemic in West Africa.

Authors:  Peter F Omonzejele
Journal:  J Bioeth Inq       Date:  2014-11-12       Impact factor: 1.352

7.  Ebola vaccine--an urgent international priority.

Authors:  Rupa Kanapathipillai; Ana Maria Henao Restrepo; Patricia Fast; David Wood; Christopher Dye; Marie-Paule Kieny; Vasee Moorthy
Journal:  N Engl J Med       Date:  2014-10-07       Impact factor: 91.245

8.  Randomised controlled trials for Ebola: practical and ethical issues.

Authors:  Clement Adebamowo; Oumou Bah-Sow; Fred Binka; Roberto Bruzzone; Arthur Caplan; Jean-François Delfraissy; David Heymann; Peter Horby; Pontiano Kaleebu; Jean-Jacques Muyembe Tamfum; Piero Olliaro; Peter Piot; Abdul Tejan-Cole; Oyewale Tomori; Aissatou Toure; Els Torreele; John Whitehead
Journal:  Lancet       Date:  2014-10-13       Impact factor: 79.321

9.  Serogroup W135 meningococcal disease, The Gambia, 2012.

Authors:  M Jahangir Hossain; Anna Roca; Grant A Mackenzie; Momodou Jasseh; Mohammad Ilias Hossain; Shah Muhammad; Manjang Ahmed; Osuorah Donatus Chidiebere; Ndiaye Malick; S M Bilquees; Usman N Ikumapayi; Baba Jeng; Baba Njie; Mamady Cham; Beate Kampmann; Tumani Corrah; Stephen Howie; Umberto D'Alessandro
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.